Orion Pharma Limited (DSE: ORIONPHARM)
Bangladesh
· Delayed Price · Currency is BDT 42.60
-0.70 (-1.62%)
At close: Nov 14, 2024
Orion Pharma Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Net Income | 455.46 | 640.94 | 846.08 | 939.06 | 665.69 | 882.35 | Upgrade
|
| Depreciation & Amortization | 527.74 | 601.12 | 498.45 | 1,019 | 936.82 | 822.06 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.21 | -0.21 | -0.08 | 5.93 | 0.05 | -0.53 | Upgrade
|
| Other Operating Activities | 16.11 | 256.66 | -225.31 | 528.16 | 857.53 | 687.8 | Upgrade
|
| Change in Accounts Receivable | 2,051 | 1,004 | -2,841 | -1,448 | -978.16 | 200.34 | Upgrade
|
| Change in Inventory | 125.35 | 45.45 | -263.32 | -133.11 | -359.57 | 270.46 | Upgrade
|
| Change in Accounts Payable | -2,221 | -327.19 | 3,226 | 1,603 | 1,010 | -1,390 | Upgrade
|
| Change in Other Net Operating Assets | 660.1 | 272.12 | -79.3 | 77.52 | -250.21 | -24.27 | Upgrade
|
| Operating Cash Flow | 1,615 | 2,493 | 1,162 | 2,592 | 1,882 | 1,449 | Upgrade
|
| Operating Cash Flow Growth | -17.58% | 114.60% | -55.17% | 37.68% | 29.95% | -33.99% | Upgrade
|
| Capital Expenditures | -2,836 | -3,859 | -2,667 | -4,277 | -1,543 | -1,348 | Upgrade
|
| Sale of Property, Plant & Equipment | -1.33 | - | - | - | 5.8 | 1.35 | Upgrade
|
| Cash Acquisitions | 1,764 | -1,376 | -379.31 | -1,633 | 89.97 | -461.35 | Upgrade
|
| Investment in Securities | 0.01 | 0.01 | -8.6 | 0.03 | -7.42 | 14.21 | Upgrade
|
| Other Investing Activities | 21.38 | 27.28 | 19.68 | 45.44 | 36.4 | 22 | Upgrade
|
| Investing Cash Flow | -1,052 | -5,208 | -3,035 | -5,864 | -1,419 | -1,772 | Upgrade
|
| Short-Term Debt Issued | - | 11.2 | 387.98 | 392.27 | - | - | Upgrade
|
| Long-Term Debt Issued | - | 3,311 | 1,784 | 3,131 | 4,960 | 926.25 | Upgrade
|
| Total Debt Issued | 559.95 | 3,322 | 2,172 | 3,523 | 4,960 | 926.25 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -3,009 | -78.69 | Upgrade
|
| Long-Term Debt Repaid | - | -28.36 | -33.66 | -40.63 | -34.54 | -7.58 | Upgrade
|
| Total Debt Repaid | -844.81 | -28.36 | -33.66 | -40.63 | -3,043 | -86.28 | Upgrade
|
| Net Debt Issued (Repaid) | -284.85 | 3,293 | 2,138 | 3,482 | 1,917 | 839.97 | Upgrade
|
| Common Dividends Paid | -108.44 | -152.94 | -324.54 | -340.17 | -373.06 | -336.19 | Upgrade
|
| Dividends Paid | -108.44 | -152.94 | -324.54 | -340.17 | -373.06 | -336.19 | Upgrade
|
| Other Financing Activities | -340.58 | -401.76 | -249.56 | -488.68 | -1,065 | -594.95 | Upgrade
|
| Financing Cash Flow | -733.87 | 2,739 | 1,564 | 2,654 | 478.37 | -91.17 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | -0 | 0 | -0 | - | - | Upgrade
|
| Net Cash Flow | -170.88 | 23.97 | -308.86 | -619.18 | 941.99 | -414.86 | Upgrade
|
| Free Cash Flow | -1,221 | -1,366 | -1,505 | -1,685 | 338.88 | 100.09 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 238.57% | -91.63% | Upgrade
|
| Free Cash Flow Margin | -10.62% | -9.81% | -15.58% | -15.56% | 4.43% | 1.15% | Upgrade
|
| Free Cash Flow Per Share | -5.22 | -5.84 | -6.43 | -7.20 | 1.45 | 0.43 | Upgrade
|
| Cash Interest Paid | 340.58 | 401.76 | 249.56 | 488.68 | 1,065 | 594.95 | Upgrade
|
| Cash Income Tax Paid | 215.18 | 117.03 | 95.73 | 40.91 | 36.47 | 47.75 | Upgrade
|
| Levered Free Cash Flow | 406.67 | -3,052 | -1,357 | -36.58 | -4,219 | -1,567 | Upgrade
|
| Unlevered Free Cash Flow | 499.95 | -2,960 | -1,249 | 103.06 | -3,771 | -1,216 | Upgrade
|
| Change in Net Working Capital | -2,380 | 336.03 | -489.01 | -2,400 | 4,134 | 1,680 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.